The US FDA is investigating the safety risks of CAR-T cancer treatment
The US Food and Drug Administration said it is investigating cancer treatments developed by Gilead Sciences, Johnson & Johnson, Novartis and others because of the risk of hospitalisation and death due to a serious safety issue.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM